StockData
MIRANasdaqPharmaceutical Preparations

MIRA PHARMACEUTICALS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.64+0.01 (+1.55%)

Close on Oct 19, 2026

Market cap
$26.98M
P/E (TTM)
–
Dividend yield
–

MIRA PHARMACEUTICALS, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Mira Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.